Accenture (NYSE:ACN) has agreed to acquire SKS Group, a consulting firm that helps banks across Germany, Austria and Switzerland modernize their technology infrastructure and address regulatory requirements using SAP S/4HANA® solutions. Terms of the transaction were not disclosed.
Chardan Capital Maintains Buy on Taysha Gene Therapies, Lowers Price Target to $32
Chardan Capital analyst Geulah Livshits maintains Taysha Gene Therapies (NASDAQ:TSHA) with a Buy and lowers the price target from $34 to $32.
